EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 253 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,636 | -21.9% | 338 | -17.6% | 0.00% | – |
| Q2 2023 | $3,374 | -5.0% | 410 | -16.3% | 0.00% | – |
| Q1 2023 | $3,553 | -17.9% | 490 | +0.4% | 0.00% | – |
| Q4 2022 | $4,329 | -13.4% | 488 | +5.6% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 462 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -77.3% | 462 | -43.1% | 0.00% | -100.0% |
| Q4 2021 | $22,000 | -63.3% | 812 | -44.1% | 0.00% | -50.0% |
| Q3 2021 | $60,000 | +22.4% | 1,452 | +66.3% | 0.00% | 0.0% |
| Q2 2021 | $49,000 | +145.0% | 873 | +83.4% | 0.00% | +100.0% |
| Q1 2021 | $20,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |